Pharmactive Biotech launches Spanish saffron extract to Asia-Pacific

Affron is all-natural, non-GMO and clinically shown to improve mood and alleviate anxiety and depression symptoms

Pharmactive Biotech Products has launched its Affron all-natural, non-GMO Spanish saffron extract (Crocus sativus L.) in the Asia-Pacific market. The company's formulation boasts the lowest dosage threshold on the market - just 28 mg per day - with scientifically backed pharmacokinetic bioavailability and rapid one-hour absorption.

Affron is standardised to Lepticrosalides, a complex of bioactive compounds responsible for the beneficial and organoleptic attributes of Affron. The capabilities of this clean-label, synthetic-free, pure plant saffron extract is backed by five clinical studies.

These compounds have been clinically shown to improve mood and alleviate anxiety and depression symptoms, as well as induce relaxation and improve sleep quality. Affron is also the first saffron extract clinically studied on adolescents.

As a high-value botanical, saffron is extremely susceptible to counterfeiting

Pharmactive grows and cultivates the saffron in its fields within the terrain of Castilla-La-Mancha in Spain. The arid plains and dry, warm Mediterranean climate of the region present ideal conditions for the cultivation of saffron.

"Crocus sativus L. species has been cultivated and consumed for centuries in Spain and its culinary and beneficial values have been long appreciated," enthused Julia Diaz, Marketing Manager of Pharmactive.

The golden threads of the saffron plant are worth nearly their weight in gold, due in part to their labour-intensive harvesting method. During the short eight weeks in autumn when they bloom, the flowers must be carefully hand picked, one at a time, and within the few hours between dawn and mid-day to avoid wilting of the delicate stigmas that form the saffron threads.

"As a high-value botanical, saffron is extremely susceptible to counterfeiting," adds Alberto Espinel, Head of R&D of Pharmactive. "The company's saffron is homegrown and manufactured in their extraction plant in Madrid. The optimised extraction process employed ensures the highest concentration of saffron's active lepticrosalides."

Affron is standardised to Lepticrosalides

Pharmactive has established a range of quality control procedures, including active compound quantification, meticulous adulteration detection measures, and microbiological and contaminant analysis to ensure consistent quality of its formulation. "We work in close cooperation with our saffron farmers, respecting the cultural heritage of this exceptional region. Their innate knowledge of saffron and how to optimally produce and harvest it using no fertiliser is key to Pharmactive's unmatched quality offering," notes Espinel.

"Furthermore, we conduct strict quality controls internally and externally through certified third parties," emphasised Espinel. "These meticulous measures provide full traceability and allow a wholly trusted source of saffron."

Affron is water-soluble and readily applicable to food formats or supplements. It is kosher and halal certified, non-GMO, non-irradiated, and has a three-year shelf-life.

Pharmactive will launch Affron at Vitafoods Asia 2019 in Singapore, Booth #I32, on 25-26 September 2019, where the Affron format for eye health, Affron EYE, is one the finalists for the Nutraingredients Awards Asia in the field of Healthy Ageing.